Zhuan Feng
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 6
- Cancer, Lipids, and Metabolism 2
-
- Ferroptosis and cancer prognosis 7
-
- RNA modifications and cancer 3
- Signaling Pathways in Disease 2
- Circular RNAs in diseases 2
-
- Virus-based gene therapy research 2
-
- Autophagy in Disease and Therapy 1
- Co-authors
- Jiao WuYifei QinJiejie GengZhi‐Nan ChenYong LiFei HuoRuo ChenQian He
- Partner nations
- ChinaUnited States
In The Last Decade
Zhuan Feng
14 papers receiving 520 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 214
- Pulmonary and Respiratory Medicine 235
- Immunology 92
- Molecular Biology 299
- Rheumatology 51
Countries citing papers authored by Zhuan Feng
This map shows the geographic impact of Zhuan Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuan Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuan Feng more than expected).
Fields of papers citing papers by Zhuan Feng
This network shows the impact of papers produced by Zhuan Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuan Feng. The network helps show where Zhuan Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhuan Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1/TLR4/STAT3 axis in M1 macrophagesbreakdown → | 2024 | 55 |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | [Ferroptosis inducer IKE ameliorate pulmonary fibrosis in collagen-induced arthritis (CIA) mice via decreasing the expression of IL-6, CCL5 and CXCL9]. | 2024 | 1 |
| 6 | TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse modelsbreakdown → | 2022 | 190 |
| 7 | 2021 | 14 | |
| 8 | 2021 | 45 | |
| 9 | 2021 | 86 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 28 | |
| 12 | 2018 | 25 | |
| 13 | 2018 | 10 | |
| 14 | 2018 | 42 |
About Zhuan Feng
Zhuan Feng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 14 papers that have together received 521 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (3 papers), Virus-based gene therapy research (2 papers), Signaling Pathways in Disease (2 papers), Circular RNAs in diseases (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Cancer Research (214 citations), Pulmonary and Respiratory Medicine (235 citations) and Immunology (92 citations). Zhuan Feng has collaborated with scholars based in China and United States. Frequent co-authors include Jiao Wu, Yifei Qin, Jiejie Geng, Zhi‐Nan Chen, Yong Li, Fei Huo, Ruo Chen, Qian He, Zhuo Pei and Zhaohui Zheng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.